LeafNLP Demos
Back to explore

Report #2873899

Received Nov 20, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
Nov 14, 2025
Onset
Nov 14, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2——

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Longer than recommended intervals; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 51-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (first dose was received on 15-DEC-2024). On 14-NOV-2025, the patient received the 2nd dose of Shingrix. On 14-NOV-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Longer than recommended intervals). Additional Information: GSK Receipt Date: 18-NOV-2025 The batch number was not provided and a request for this information has been made.